Marotta Asset Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,959
Closed -$995K 104
2026
Q1
$995K Sell
4,959
-42
-0.8% -$8.1K 0.18% 56
2025
Q4
$919K Sell
5,001
-114
-2% -$20K 0.17% 55
2025
Q3
$863K Sell
5,115
-221
-4% -$33.4K 0.16% 57
2025
Q2
$746K Sell
5,336
-1,163
-18% -$163K 0.15% 57
2025
Q1
$1.01M Buy
6,499
+206
+3% +$29.8K 0.2% 55
2024
Q4
$829K Sell
6,293
-206
-3% -$28.8K 0.17% 57
2024
Q3
$1.01M Sell
6,499
-94
-1% -$15.2K 0.2% 55
2024
Q2
$1.03M Buy
6,593
+188
+3% +$28.3K 0.21% 55
2024
Q1
$868K Sell
6,405
-49
-0.8% -$6.49K 0.18% 56
2023
Q4
$869K Sell
6,454
-124
-2% -$16.1K 0.19% 54
2023
Q3
$891K Sell
6,578
-119
-2% -$16.3K 0.21% 52
2023
Q2
$959K Buy
+6,697
New +$985K 0.21% 49
2022
Q4
$916K Sell
6,754
-73
-1% -$9.15K 0.22% 50
2022
Q3
$749K Sell
6,827
-33
-0.5% -$4.19K 0.2% 51
2022
Q2
$905K Sell
6,860
-211
-3% -$27.7K 0.22% 51
2022
Q1
$938K Buy
7,071
+120
+2% +$14.4K 0.22% 50
2021
Q4
$810K Buy
6,951
+207
+3% +$24.4K 0.18% 52
2021
Q3
$810K Buy
6,744
+14
+0.2% +$1.63K 0.2% 46
2021
Q2
$812K Buy
6,730
+957
+17% +$105K 0.19% 48
2021
Q1
$572K Buy
+5,773
New +$580K 0.15% 52

Other funds holding AZN

Marotta Asset Management's AZN Position: Q2 2026 in Review

Marotta Asset Management sold out of AstraZeneca (AZN) in Q2 2026, closing a stake of 4,959 shares — an estimated $995K sold.

Marotta Asset Management first reported a position in AZN in Q1 2021 and held it in 20 quarters. The position peaked at $1.03M in Q2 2024. 700 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Marotta Asset Management reported no remaining AstraZeneca position as of Q2 2026 after selling out during the quarter.
  • Marotta Asset Management sold 4,959 AstraZeneca shares in Q2 2026, an estimated $995K.
  • Marotta Asset Management first reported a position in AstraZeneca in Q1 2021 and held it in 20 quarters.
  • Marotta Asset Management's AstraZeneca position peaked at $1.03M in Q2 2024.
  • 700 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Marotta Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.